LCMC3: Immune cell subtypes predict nodal status and pathologic response after neoadjuvant atezolizumab in resectable NSCLC Meeting Abstract
| Authors: | Oezkan, F.; Seweryn, M.; Pietrzak, M.; Byun, W. Y.; Owen, D.; Schulze, K.; Nicholas, A.; Hilz, S.; Grindheim, J.; Johnson, A.; Kwiatkowski, D.; Wistuba, I.; Johnson, B.; Kris, M.; Rusch, V.; Lee, J.; Lozanski, G.; Carbone, D. |
| Abstract Title: | LCMC3: Immune cell subtypes predict nodal status and pathologic response after neoadjuvant atezolizumab in resectable NSCLC |
| Meeting Title: | 2021 World Conference on Lung Cancer |
| Keywords: | immunophenotype; atezolizumab; resectable nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2021 Sep 8-14 |
| Meeting Location: | Virtual event |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S910 |
| End Page: | S911 |
| Language: | English |
| ACCESSION: | WOS:000709606500151 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.08.152 |
| Notes: | Meeting Abstract: MA09.01 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
